Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05138939 · ClinicalTrials.gov registry record · NA
Effects of Japanese Red Wines on Vascular Function in Adult Men
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05138939: Completed NA study, sponsored by University of California, Davis.
NCT05138939 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05138939, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The overall objective of this study is to investigate the effects of different types of red wine on markers of endothelial function and platelet aggregation.
Primary Outcome
Endothelial function
Interventions
- OTHER Control
- OTHER Red wine A
- OTHER Red wine B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-11-17 |
| Est. Completion | 2023-02-04 |
| Phase | NA |
What the finished NCT05138939 record still lists
NCT05138939 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT05138939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05138939 about?
NCT05138939 is a clinical study titled "Effects of Japanese Red Wines on Vascular Function in Adult Men". The overall objective of this study is to investigate the effects of different types of red wine on markers of endothelial function and platelet aggregation.
What is the current status of trial NCT05138939?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-11-17. Estimated completion is 2023-02-04.
What interventions are being tested in trial NCT05138939?
The interventions under investigation include: Control (OTHER), Red wine A (OTHER), Red wine B (OTHER).
Who is sponsoring clinical trial NCT05138939?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05138939's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI